Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Elevance Health stock hits 52-week high at 427.07 USD By Investing.com - Investing.com India
Elevance Health stock hits 52-week high at 427.07 USD By Investing.comInvesting.com India
Bank of Baroda pays $600 million to settle NMC Health litigation
The settlement resolves all claims between the parties without any admission of liability or wrongdoing by the bank, according to the filing. Apart from the settlement amount, the terms of the agreement remain confidential.
Bank of Baroda settles NMC Health dispute for $600 million; Q1 credit grows 17%
Bank of Baroda has settled a significant legal dispute with NMC Health entities for USD 600 million, resolving claims under UAE and UK regulations. The bank's Abu Dhabi branch facilitated the payment, concluding proceedings without admitting liability. In other news, BoB reported robust financial performance, with credit growth reaching 17% and total deposits rising 14% in the first quarter of FY27.
Bank of Baroda falls after $600 million settlement in NMC Health dispute
Bank of Baroda said it has agreed to pay $600 million (approximately ₹5,700 crore) to resolve the long-running legal dispute.
Bank of Baroda Settles NMC Health Dispute For Rs 5,700 Crore, Shares Fall 4%
The case involving Bank of Baroda was related to insolvency
Bank of Baroda slumps after settling NMC Health litigation for $600 million
Bank of Baroda tumbled 4.31% to Rs 259.80 after the bank said that it has entered into an out-of-court settlement with the joint administrators of NMC Health PLC, NMC Healthcare Ltd and NMC Holding Ltd.
Sensex gains 579 points, Nifty ends above 24,150: 5 reasons why stock market rose today
Indian indices rose, Sensex up 579 pts, Nifty above 24,150, led by IT stocks, oil companies. Bank of Baroda fell on NMC Health settlement.
Bank of Baroda falls 4% on NMC Health litigation settlement for ₹5,700 cr
Bak of Baroda has announced an out-of-court settlement with in the NMC Health litigation for $600 million (₹5,700 crore).
Cracks in cola kingdom: India's duopoly faces biggest test in decades
India's cola market is undergoing a significant transformation, moving beyond the traditional Coca-Cola vs. PepsiCo rivalry. Reliance's Campa revival ignited a price war, while ITC's new premium, sugar-free coconut cola signals a shift towards health, premiumization, and niche offerings. This evolving landscape caters to health-conscious consumers seeking alternatives, indicating a more dynamic and diversified future for the Indian beverage sector.
Prudential HCL Health gets IRDAI licence, becomes India’s 8th standalone health insurer
Prudential HCL Health Insurance gets IRDAI nod as a standalone health insurer, marking India's third new insurance entrant of 2026.
Prudential HCL Health Insurance gets IRDAI nod
India's health insurance sector welcomes a new player as Prudential HCL Health Insurance receives regulatory approval. This joint venture, backed by Prudential Group Holdings and HCL Group, aims to tap into the growing demand for medical cover. The approval also signals broader regulatory changes, including new accounting standards and a policyholder protection fund. Prudential's presence in India is significantly expanding with this new health insurance arm.
ITC enters cola business to add more fizz to beverages portfolio
India's carbonated soft drinks market is intensifying as ITC launches a premium sugar-free Coconut Cola, aiming to compete with global giants Coca-Cola and PepsiCo. This move follows Reliance Industries' aggressive pricing strategy with its revived Campa brand. ITC plans to expand its beverage offerings, focusing on the premium, health-conscious segment, which is experiencing rapid growth due to increasing consumer preference for low- and no-sugar options.